Drug Profile
Research programme: cytokine inhibitors - Bioniz
Alternative Names: BJNZ132-2; BNZ 3; BNZ132-3; Research programme: multi-cytokine platform therapeutics - EquilliumLatest Information Update: 26 Mar 2024
Price :
$50
*
At a glance
- Originator Bioniz
- Class Peptides
- Mechanism of Action Interleukin 4 receptor antagonists; Interleukin 9 receptor antagonists; Interleukin receptor common gamma subunit inhibitors; Interleukin-21 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
- No development reported Rheumatoid arthritis